Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...